{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:04:06Z","timestamp":1770980646445,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00508-025-02586-8","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:39:43Z","timestamp":1758631183000},"page":"113-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical-Pathological Conference Series from the Medical University of Graz"],"prefix":"10.1007","volume":"138","author":[{"given":"Elisabeth","family":"Fabian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Gornicec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Kneidinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"W\u00f6lfler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentine","family":"Moazedi-F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijan","family":"Puseljic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fuchsj\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guenter J.","family":"Krejs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"2586_CR1","unstructured":"CDC 2024 https:\/\/www.cdc.gov\/q-fever\/about\/index.html. Accessed 24 May 2025."},{"key":"2586_CR2","unstructured":"Kersh GJ. Q fever: epidemiology, microbiology, and diagnostic tests. 2025. https:\/\/www-1uptodate-1com-1p6d23wkt0ff5.han.medunigraz.at\/contents\/q-fever-epidemiology-microbiology-and-diagnostic-tests?search=coxiella%20burnetii&source=search_result&selectedTitle=3~64&usage_type=default&display_rank=3. Accessed 24 May 2025."},{"key":"2586_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/zph.12896","volume":"69","author":"CC Cherry","year":"2022","unstructured":"Cherry\u00a0CC, Nichols Heitman\u00a0K, Bestul\u00a0NC, Kersh\u00a0GJ. Acute and chronic Q fever national surveillance\u2014United States, 2008\u20132017. Zoonoses Public Health. 2022;69:73.","journal-title":"Zoonoses Public Health"},{"key":"2586_CR4","unstructured":"Q fever | annual epidemiological report for 2019. European centre for disease prevention and control. 2021. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER-Q-fever-2019.pdf. Accessed 9 July 2024."},{"key":"2586_CR5","unstructured":"King TE. Hypersensitivity pneumonitis (extrinsic allergic alveolitis): epidemiology, causes, and pathogenesis. 2025. https:\/\/www-1uptodate-1com-1p6d23wkt0ff5.han.medunigraz.at\/contents\/hypersensitivity-pneumonitis-extrinsic-allergic-alveolitis-epidemiology-causes-and-pathogenesis?search=exogenous%20allergic%20alveolitis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. Accessed 24 May 2025."},{"issue":"27","key":"2586_CR6","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck\u00a0DB, Ferrada\u00a0MA, Sikora\u00a0KA, Ombrello\u00a0AK, Collins\u00a0JC, Pei\u00a0W, et\u00a0al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N\u00a0Engl J Med. 2020;383(27):2628\u201338.","journal-title":"N Engl J Med"},{"issue":"26","key":"2586_CR7","first-page":"3591","volume":"137","author":"PC Grayson","year":"2021","unstructured":"Grayson\u00a0PC, Patel\u00a0BA, Young\u00a0NS. VEXAS syndrome. Blood. 2021;137(26):3591\u20134.","journal-title":"Blood"},{"issue":"4","key":"2586_CR8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3324\/haematol.2021.280238","volume":"107","author":"RJ Stubbins","year":"2022","unstructured":"Stubbins\u00a0RJ, McGinnis\u00a0E, Johal\u00a0B, Chen\u00a0LY, Wilson\u00a0L, Cardona\u00a0DO, Nevill\u00a0TJ. VEXAS syndrome in a\u00a0female patient with constitutional 45,X (Turner syndrome). Haematologica. 2022;107(4):1011\u20133.","journal-title":"Haematologica"},{"issue":"1","key":"2586_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.reuma.2023.10.006","volume":"20","author":"MP Loeza-Uribe","year":"2024","unstructured":"Loeza-Uribe\u00a0MP, Hinojosa-Azaola\u00a0A, S\u00e1nchez-Hern\u00e1ndez\u00a0BE, Crisp\u00edn\u00a0JC, Apodaca-Ch\u00e1vez\u00a0E, Ferrada\u00a0MA, Mart\u00edn-Nares\u00a0E. VEXAS syndrome: Clinical manifestations, diagnosis, and treatment. Reumatol Clin. 2024;20(1):47\u201356.","journal-title":"Reumatol Clin"},{"issue":"2","key":"2586_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/1744666X.2023.2157262","volume":"19","author":"A Al-Hakim","year":"2023","unstructured":"Al-Hakim\u00a0A, Savic\u00a0S. An update on VEXAS syndrome. Expert Rev Clin Immunol. 2023;19(2):203\u201315.","journal-title":"Expert Rev Clin Immunol"},{"key":"2586_CR11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.18632\/oncotarget.28646","volume":"15","author":"M Sakuma","year":"2024","unstructured":"Sakuma\u00a0M, Haferlach\u00a0T, Walter\u00a0W. UBA1 dysfunction in VEXAS and cancer. Oncotarget. 2024;15:644\u201358.","journal-title":"Oncotarget"},{"key":"2586_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrm2673","volume":"10","author":"BA Schulman","year":"2009","unstructured":"Schulman\u00a0BA, Harper\u00a0JW. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat Rev Mol Cell Biol. 2009;10:319\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2586_CR13","doi-asserted-by":"publisher","first-page":"e0174","DOI":"10.1199\/tab.0174","volume":"12","author":"J Callis","year":"2014","unstructured":"Callis\u00a0J. The ubiquitination machinery of the ubiquitin system. Arabidopsis Book. 2014;12:e174.","journal-title":"Arabidopsis Book"},{"issue":"8","key":"2586_CR14","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.4161\/cc.19978","volume":"11","author":"P Moudry","year":"2012","unstructured":"Moudry\u00a0P, Lukas\u00a0C, Macurek\u00a0L, Hanzlikova\u00a0H, Hodny\u00a0Z, Lukas\u00a0J, Bartek J. Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage. Cell Cycle. 2012;11(8):1573\u201382.","journal-title":"Cell Cycle"},{"issue":"10","key":"2586_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.molmed.2015.08.003","volume":"21","author":"EJN Groen","year":"2015","unstructured":"Groen\u00a0EJN, Gillingwater\u00a0TH. UBA1: at the crossroads of ubiquitin homeostasis and neurodegeneration. Trends Mol Med. 2015;21(10):622\u201332.","journal-title":"Trends Mol Med"},{"key":"2586_CR16","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1182\/blood.2022016985","volume":"140","author":"MA Ferrada","year":"2022","unstructured":"Ferrada\u00a0MA, Savic\u00a0S, Cardona\u00a0DO, Collins\u00a0JC, Alessi\u00a0H, Gutierrez-Rodrigues\u00a0F, et\u00a0al. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood. 2022;140:1496\u2013506.","journal-title":"Blood"},{"issue":"26","key":"2586_CR17","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1182\/blood.2020010286","volume":"137","author":"JA Poulter","year":"2021","unstructured":"Poulter\u00a0JA, Collins\u00a0JC, Cargo\u00a0C, De Tute RM, Evans P, Ospina Cardona D, Bowen DT, Cunnington JR, Baguley E, Quinn M, Green M, McGonagle D, Beck DB, Werner A, Savic S. Novel somatic mutations in UBA1 as a\u00a0cause of VEXAS syndrome. Blood. 2021;137(26):3676\u201381.","journal-title":"Blood"},{"issue":"26","key":"2586_CR18","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1182\/blood.2020010177","volume":"137","author":"E Bourbon","year":"2021","unstructured":"Bourbon\u00a0E, Heiblig\u00a0M, Gerfaud\u00a0VM, Barba\u00a0T, Durel\u00a0CA, Lega\u00a0JC, Barraco\u00a0F, S\u00e8ve\u00a0P, Jamilloux\u00a0Y, Sujobert\u00a0P. Therapeutic options in VEXAS syndrome: insights from a\u00a0retrospective series. Blood. 2021;137(26):3682\u20134.","journal-title":"Blood"},{"key":"2586_CR19","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1093\/rheumatology\/keab524","volume":"60","author":"M Templ\u00e9","year":"2021","unstructured":"Templ\u00e9\u00a0M, Duroyon\u00a0E, Croizier\u00a0C, Rossignol\u00a0J, Huet\u00a0T, Friedrich\u00a0C, Zalmai\u00a0L, Priollet\u00a0P, Hayem\u00a0G, Tournillhac\u00a0O, Le Guenno\u00a0G, Hermine\u00a0O, Terrier\u00a0B, Kosmider\u00a0O. Atypical splice-site mutations causing VEXAS syndrome. Rheumatol. 2021;60:e435\u20137.","journal-title":"Rheumatol"},{"key":"2586_CR20","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s44318-024-00046-z","volume":"43","author":"JC Collins","year":"2024","unstructured":"Collins\u00a0JC, Magaziner\u00a0SJ, English\u00a0M, Hassan\u00a0B, Chen\u00a0X, Balanda\u00a0N, Anderson\u00a0M, Lam\u00a0A, Fernandez-Pol\u00a0S, Kwong\u00a0B, Greenberg\u00a0PL, Terrier\u00a0B, Likhite\u00a0ME, Kosmider O, Wang Y, Samara NL, Walters KJ, Beck DB, Werner A. Shared and distinct mechanisms of UBA1 inactivation across different diseases. EMBO\u00a0J. 2024;43:1919\u201346.","journal-title":"EMBO J"},{"key":"2586_CR21","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/art.42471","volume":"75","author":"B Stiburkova","year":"2023","unstructured":"Stiburkova\u00a0B, Pavelcova\u00a0K, Belickova\u00a0M, Magaziner\u00a0SJ, Collins\u00a0JC, Werner\u00a0A, Beck\u00a0DB, Balajkova\u00a0V, Salek\u00a0C, Vostry\u00a0M, Mann\u00a0H, Vencovsky\u00a0J. Novel somatic UBA1 variant in a\u00a0patient with VEXAS syndrome. Arthritis Rheumatol. 2023;75:1285\u201390.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"2586_CR22","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1093\/rheumatology\/keab392","volume":"60","author":"T Barba","year":"2021","unstructured":"Barba\u00a0T, Jamilloux\u00a0Y, Durel\u00a0CA, Bourbon\u00a0E, Mestrallet\u00a0F, Sujobert\u00a0P, Hot\u00a0A. VEXAS syndrome in a\u00a0woman. Rheumatol. 2021;60(11):e402\u2013e3.","journal-title":"Rheumatol"},{"key":"2586_CR23","doi-asserted-by":"publisher","first-page":"11843","DOI":"10.1038\/ncomms11843","volume":"7","author":"MJ Machiela","year":"2016","unstructured":"Machiela\u00a0MJ, Zhou\u00a0W, Karlins\u00a0E, Sampson\u00a0JN, Freedman\u00a0ND, Yang\u00a0Q, et\u00a0al. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X\u00a0chromosome. Nat Commun. 2016;7:11843.","journal-title":"Nat Commun"},{"key":"2586_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41584-022-00778-4","volume":"18","author":"DB Beck","year":"2022","unstructured":"Beck\u00a0DB, Werner\u00a0A, Kastner\u00a0DL, Aksentijevich\u00a0I. Disorders of ubiquitylation: unchained inflammation. Nat Rev Rheumatol. 2022;18:435\u201347.","journal-title":"Nat Rev Rheumatol"},{"key":"2586_CR25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41577-023-00838-0","volume":"23","author":"G Di Conza","year":"2023","unstructured":"Di Conza\u00a0G, Ho\u00a0PC, Cubillos-Ruiz\u00a0JR, Huang\u00a0SC. Control of immune cell function by the unfolded protein response. Nat Rev Immunol. 2023;23:546\u201362.","journal-title":"Nat Rev Immunol"},{"key":"2586_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri.2016.62","volume":"16","author":"J Grootjans","year":"2016","unstructured":"Grootjans\u00a0J, Kaser\u00a0A, Kaufman\u00a0RJ, Blumberg\u00a0RS. The unfolded protein response in immunity and inflammation. Nat Rev Immunol. 2016;16:469\u201384.","journal-title":"Nat Rev Immunol"},{"key":"2586_CR27","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41467-024-44811-4","volume":"15","author":"O Kosmider","year":"2024","unstructured":"Kosmider\u00a0O, Poss\u00e9m\u00e9\u00a0C, Templ\u00e9\u00a0M, Corneau\u00a0A, Carbone\u00a0F, Duroyon\u00a0E, Breillat\u00a0P, et\u00a0al. VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation. Nat Commun. 2024;15:910.","journal-title":"Nat Commun"},{"key":"2586_CR28","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1016\/S2352-3026(23)00375-7","volume":"11","author":"V Lacombe","year":"2024","unstructured":"Lacombe\u00a0V, Hadjadj\u00a0J, Georgin-Lavialle\u00a0S, Lavigne\u00a0C, Genevi\u00e8ve\u00a0F, Kosmider\u00a0O. Vacuoles in bone marrow progenitors: VEXAS syndrome and beyond. Lancet Haematol. 2024;11:e160\u20137.","journal-title":"Lancet Haematol"},{"key":"2586_CR29","first-page":"487","volume":"13(3","author":"KY Yeung","year":"1988","unstructured":"Yeung\u00a0KY, Klug\u00a0PP, Lessin\u00a0LS. Alcohol-induced vacuolization in bone marrow cells: ultrastructure and mechanism of formation. Blood Cells. 1988;13(3:487\u2013502.","journal-title":"Blood Cells"},{"issue":"1","key":"2586_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/MOH.0b013e32834da9d2","volume":"19","author":"J Lazarchick","year":"2012","unstructured":"Lazarchick\u00a0J. Update on anemia and neutropenia in copper deficiency. Curr Opin Hematol. 2012;19(1):58\u201360.","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"2586_CR31","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3324\/haematol.12121","volume":"93","author":"AS Haddad","year":"2008","unstructured":"Haddad\u00a0AS, Subbiah\u00a0V, Lichtin\u00a0AE, Theil\u00a0KS, Maciejewski\u00a0JP. Hypocupremia and bone marrow failure. Haematologica. 2008;93(1):e1\u2013e5.","journal-title":"Haematologica"},{"issue":"4","key":"2586_CR32","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1182\/blood-2002-01-0256","volume":"100","author":"XT Gregg","year":"2002","unstructured":"Gregg\u00a0XT, Reddy\u00a0V, Prchal\u00a0JT. Copper deficiency masquerading as myelodysplastic syndrome. Blood. 2002;100(4):1493\u20135.","journal-title":"Blood"},{"issue":"5","key":"2586_CR33","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/leu.2008.389","volume":"23","author":"EJ Houwerzijl","year":"2009","unstructured":"Houwerzijl\u00a0EJ, Pol\u00a0HW, Blom\u00a0NR, van der Want\u00a0JJ, de Wolf\u00a0JT, Vellenga\u00a0E. Erythroid precursors from patients with low-risk myelodysplasiademonstrate ultrastructural features of enhanced autophagy of mitochondria. Leukemia. 2009;23(5):886\u201391.","journal-title":"Leukemia"},{"key":"2586_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/ajcp\/aqad186","volume":"161","author":"H Olteanu","year":"2024","unstructured":"Olteanu\u00a0H, Patnaik\u00a0M, Koster\u00a0MJ, Herrick\u00a0JL, Chen\u00a0D, He\u00a0R, Viswanatha\u00a0D, Warrington\u00a0KJ, Go\u00a0RS, Mangaonkar\u00a0AA, Kourelis\u00a0T, Hines\u00a0A, Gibson\u00a0SE, Peterson JF, Reichard KK.\u00a0Comprehensive morphologic characterization of bone marrow biopsy findings in a\u00a0large cohort of patients with VEXAS syndrome: A\u00a0single-institution longitudinal study of 111 bone marrow samples from 52\u00a0patients. Am J Clin Pathol. 2024;161:609\u201324.","journal-title":"Am J Clin Pathol"},{"key":"2586_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1182\/blood.2019000942","volume":"136","author":"AJ Menssen","year":"2020","unstructured":"Menssen\u00a0AJ, Walter\u00a0MJ. Genetics of progression from MDS to secondary leukemia. Blood. 2020;136:50\u201360.","journal-title":"Blood"},{"key":"2586_CR36","first-page":"103386","volume":"71","author":"G Battipaglia","year":"2023","unstructured":"Battipaglia\u00a0G, Vincenzi\u00a0A, Falconi\u00a0G, Fiore\u00a0A, D\u2019Agostino\u00a0F, Iannotta\u00a0R, Grimaldi\u00a0F, Gurnari\u00a0C, Galossi\u00a0E, Cris\u00e0\u00a0E, Bonello\u00a0F, Scalia\u00a0G, Izzo\u00a0B,\u00a0Voso MT, Pane F.  New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia. Curr Res Transl Med. 2023;71:103386.","journal-title":"Curr Res Transl Med"},{"issue":"4","key":"2586_CR37","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jaad.2022.10.052","volume":"88","author":"\u00c8 Zakine","year":"2023","unstructured":"Zakine \u00c8, Papageorgiou\u00a0L, Bourguiba\u00a0R, Mekinian\u00a0A, Terrier\u00a0B, Kosmider\u00a0O, et\u00a0al. Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: a\u00a0multicenter retrospective study of 59\u00a0cases. J\u00a0Am Acad Dermatol. 2023;88(4):917\u201320.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2586_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40164-022-00262-5","volume":"11","author":"V Lacombe","year":"2022","unstructured":"Lacombe\u00a0V, Beucher\u00a0A, Urbanski\u00a0G, Le Corre\u00a0Y, Cottin\u00a0L, Crou\u00e9\u00a0A, et\u00a0al. Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome. Exp Hematol Oncol. 2022;11(1):6.","journal-title":"Exp Hematol Oncol"},{"issue":"22","key":"2586_CR39","first-page":"00181","volume":"S0190\u20139622","author":"D Sterling","year":"2022","unstructured":"Sterling\u00a0D, Duncan\u00a0ME, Philippidou\u00a0M, Salisbury\u00a0JR, Kulasekararaj\u00a0AG, Basu\u00a0TN. VEXAS syndrome (vacuoles, E1 enzyme, X\u2011linked, autoinflammatory, somatic) for the dermatologist. J\u00a0Am Acad Dermatol. 2022;S0190\u20139622(22):181\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"16","key":"2586_CR40","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","volume":"5","author":"IE Obiorah","year":"2021","unstructured":"Obiorah\u00a0IE, Patel\u00a0BA, Groarke\u00a0EM, Wang\u00a0W, Trick\u00a0M, Ombrello\u00a0AK, et\u00a0al. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv. 2021;5(16):3203\u201315.","journal-title":"Blood Adv"},{"key":"2586_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1053\/j.seminhematol.2021.10.006","volume":"58","author":"EM Groarke","year":"2021","unstructured":"Groarke\u00a0EM, Dulau-Florea\u00a0AE, Kanthi\u00a0Y. Thrombotic manifestations of VEXAS syndrome. Semin Hematol. 2021;58:230\u20138.","journal-title":"Semin Hematol"},{"issue":"6","key":"2586_CR42","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/RHU.0000000000001905","volume":"29","author":"MJ Koster","year":"2023","unstructured":"Koster\u00a0MJ, Samec\u00a0MJ, Warrington\u00a0KJ. VEXAS syndrome\u2014a\u00a0review of pathophysiology, presentation, and prognosis. J\u00a0Clin Rheumatol. 2023;29(6):298\u2013306.","journal-title":"J Clin Rheumatol"},{"key":"2586_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jdcr.2022.02.022","volume":"23","author":"A Goyal","year":"2022","unstructured":"Goyal\u00a0A, Narayanan\u00a0D, Wong\u00a0W, Laga\u00a0AC, Connell\u00a0NT, Ritter\u00a0SY, et\u00a0al. Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X\u2011linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome. JAAD Case Rep. 2022;23:15\u20139.","journal-title":"JAAD Case Rep"},{"issue":"11","key":"2586_CR44","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1136\/annrheumdis-2021-220876","volume":"80","author":"Y Kirino","year":"2021","unstructured":"Kirino\u00a0Y, Takase-Minegishi\u00a0K, Tsuchida\u00a0N, Hirahara\u00a0L, Kunishita\u00a0Y, Yoshimi\u00a0R, et\u00a0al. Tocilizumab in VEXAS relapsing polychondritis: a\u00a0single-center pilot study in Japan. Ann Rheum Dis. 2021;80(11):1501\u20132.","journal-title":"Ann Rheum Dis"},{"key":"2586_CR45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.medcli.2022.06.018","volume":"159","author":"J Hern\u00e1ndez-Rodr\u00edguez","year":"2022","unstructured":"Hern\u00e1ndez-Rodr\u00edguez\u00a0J, Mensa-Vilar\u00f3\u00a0A, Ar\u00f3stegui\u00a0JI. Paradigm shift in monogenic autoinflammatory diseases and systemic vasculitis: the VEXAS syndrome. Med Clin. 2022;159:489\u201396.","journal-title":"Med Clin"},{"key":"2586_CR46","doi-asserted-by":"publisher","first-page":"678927","DOI":"10.3389\/fimmu.2021.678927","volume":"12","author":"F Staels","year":"2021","unstructured":"Staels\u00a0F, Betrains\u00a0A, Woei-A-Jin\u00a0FJSH, Boeckx\u00a0N, Beckers\u00a0M, Bervoets\u00a0A, et\u00a0al. Case report: VEXAS syndrome: from mild symptoms to life-threatening macrophage activation syndrome. Front Immunol. 2021;12:678927.","journal-title":"Front Immunol"},{"key":"2586_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.seminhematol.2021.09.001","volume":"58","author":"M Heiblig","year":"2021","unstructured":"Heiblig\u00a0M, Patel\u00a0BA, Groarke\u00a0EM, Bourbon\u00a0E, Sujobert\u00a0P. Toward a\u00a0pathophysiology inspired treatment of VEXAS syndrome. Semin Hematol. 2021;58:239\u201346.","journal-title":"Semin Hematol"},{"issue":"10","key":"2586_CR48","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/ard-2024-225640","volume":"83","author":"J Hadjadj","year":"2024","unstructured":"Hadjadj\u00a0J, Nguyen\u00a0Y, Mouloudj\u00a0D, Bourguiba\u00a0R, Heiblig\u00a0M, Aloui\u00a0H, et\u00a0al. Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX. Ann Rheum Dis. 2024;83(10):1358\u201367.","journal-title":"Ann Rheum Dis"},{"key":"2586_CR49","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1097\/HS9.0000000000000661","volume":"5","author":"MHGP Raaijmakers","year":"2021","unstructured":"Raaijmakers\u00a0MHGP, Hermans\u00a0M, Aalbers\u00a0A, Rijken\u00a0M, Dalm\u00a0VASH, van Daele\u00a0P, et\u00a0al. Azacytidine treatment for VEXAS syndrome. Hemasphere. 2021;5:e661.","journal-title":"Hemasphere"},{"issue":"2","key":"2586_CR50","first-page":"196","volume":"75","author":"V Jachiet","year":"2025","unstructured":"Jachiet\u00a0V, Comont\u00a0T, Kosmider\u00a0O, Zhao\u00a0LP, Mekinian\u00a0A, Fain\u00a0O, Hadjadj\u00a0J. Syndrome VEXAS [VEXAS Syndrome]. Rev Prat. 2025;75(2):196\u2013200.","journal-title":"Rev Prat"},{"issue":"7","key":"2586_CR51","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1016\/S2665-9913(25)00034-7","volume":"7","author":"A Al-Hakim","year":"2025","unstructured":"Al-Hakim\u00a0A, Trikha\u00a0R, Phyu Htut\u00a0EE, Chowdhury\u00a0O, MacLennan\u00a0CA, Chee\u00a0A, Kaul\u00a0A, Poulter\u00a0JA, Cargo\u00a0C, Wason\u00a0JMS, Ahmed\u00a0S, Basu\u00a0TN, Gogoi\u00a0S, Galloway\u00a0J, Jolles\u00a0S, Mistry\u00a0A, Payne\u00a0EM, Tattersall\u00a0RS, Youngstein\u00a0T, Lachmann\u00a0HJ, Kulasekararaj\u00a0A, Savic\u00a0S. Treatment outcomes in patients with VEXAS syndrome: a\u00a0retrospective cohort study. Lancet Rheumato. 2025;7(7):e472\u2013e84.","journal-title":"Lancet Rheumato"},{"key":"2586_CR52","doi-asserted-by":"publisher","first-page":"983939","DOI":"10.3389\/fmed.2022.983939","volume":"9","author":"R Watanabe","year":"2022","unstructured":"Watanabe\u00a0R, Kiji\u00a0M, Hashimoto\u00a0M. Vasculitis associated with VEXAS syndrome: A\u00a0literature review. Front Med. 2022;9:983939.","journal-title":"Front Med"},{"issue":"4","key":"2586_CR53","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/03009742.2022.2045791","volume":"51","author":"E Mart\u00edn-Nares","year":"2022","unstructured":"Mart\u00edn-Nares\u00a0E, Vargas-Seraf\u00edn\u00a0C, Delgado-de la Mora\u00a0MJ, Montante-Montes de Oca\u00a0D, Grayson\u00a0PC, Larios\u00a0E, Crisp\u00edn\u00a0JC. Orbital and periorbital inflammation in VEXAS syndrome. Scand J Rheumatol. 2022;51(4):338\u201341.","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"2586_CR54","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1093\/rheumatology\/kead240","volume":"62","author":"Z Boyadzhieva","year":"2023","unstructured":"Boyadzhieva\u00a0Z, Ruffer\u00a0N, K\u00f6tter\u00a0I, Krusche\u00a0M. How to treat VEXAS syndrome: a\u00a0systematic review on effectiveness and safety of current treatment strategies. Rheumatol. 2023;62(11):3518\u201325.","journal-title":"Rheumatol"},{"issue":"4","key":"2586_CR55","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jama.2022.24836","volume":"329","author":"DB Beck","year":"2023","unstructured":"Beck\u00a0DB, Bodian\u00a0DL, Shah\u00a0V, Mirshahi\u00a0UL, Kim\u00a0J, Ding\u00a0Y, et\u00a0al. Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a\u00a0clinical population. JAMA. 2023;329(4):318\u201324.","journal-title":"JAMA"},{"issue":"10","key":"2586_CR56","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1093\/rheumatology\/keae123","volume":"63","author":"R Echerbault","year":"2024","unstructured":"Echerbault R, Bourguiba R, Georgin-Lavialle S, Lavigne C, Ravaiau C, Lacombe V. Comparing clinical features between males and females with VEXAS syndrome: data from literature analysis of patient reports. Rheumatology (Oxford). 2024;63(10):2694\u2013700.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"2586_CR57","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/ard-2023-224819","volume":"83","author":"B de Valence","year":"2024","unstructured":"de Valence B, Delaune M, Nguyen Y, Jachiet V, Heiblig M, Jean A, et al. Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry. Ann Rheum Dis. 2024;83(3):372\u201381.","journal-title":"Ann Rheum Dis"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-025-02586-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:04:05Z","timestamp":1770977045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-025-02586-8"}},"subtitle":["Case\u00a0No\u00a0183: A\u00a057-year-old farmer with fever, cough, maculopapular rash and bicytopenia"],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":57,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2586"],"URL":"https:\/\/doi.org\/10.1007\/s00508-025-02586-8","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"17 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.\u00a0Fabian, M.\u00a0Gornicec, N.\u00a0Kneidinger, A.\u00a0W\u00f6lfler, F.\u00a0Moazedi-F\u00fcrst, M.\u00a0Puseljic, M.\u00a0Fuchsj\u00e4ger, R.\u00a0Krause and G.J.\u00a0Krejs declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}